|
Sign In to gain access to subscriptions and/or personal tools.
|
Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus
A. Zonana-Nacach
Unidad de Investigación Clínica y Epidemiología, Hospital General Regional No. 20, Tijuana, Baja California, Mexico, zonanaa{at}yahoo.com
P. Yañez
Departamento de Reumatología, Hospital de Especialidades Centro Médico Nacional, Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico
F.J. Jiménez-Balderas
Departamento de Reumatología, Hospital de Especialidades Centro Médico Nacional, Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico
A. Camargo-Coronel
Departamento de Reumatología, Hospital de Especialidades Centro Médico Nacional, Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico
Systemic lupus erythematosus (SLE) is a clinical syndrome of varying severity. Although the survival and prognosis of SLE have steadily improved, there is a group of patients who present an acute fatal outcome despite aggressive therapy. We designed this study to evaluate the factors associated with mortality in patients with acute severe SLE. During 2004—06, 41 Mexican SLE patients that could not be managed in the out-patient clinic and with acute severe major organ system involvement [nephritis, severe thrombocytopenia (platelet count below 20 000 per µL) acute neuropsychiatric pulmonary, gastrointestinal or cardiac disease and generalized vasculitis] were studied. During the first admission, disease activity (SLE Disease Activity Index (SLEDAI), SLE Activity Measured), damage [SLE International Collaborating Clinics (SLICC)], and therapy were assessed. Survival using Kaplan—Meier curves, odd ratios with 95% confidence interval and logistic regression analysis were used to determine risk factors for mortality. Ninety percent were female with a mean age of 29 ± 19 years and mean disease duration of 21 ± 9 months. The principal causes of first admission were renal (27%), SNC (22%) and cardiopulmonary (15%). After a mean follow-up of 9.7 ± 6 months, 16 (39%) patients died. Deceased patients had significantly higher SLEDAI (P = 0.004), and SLICC (P = 0.03) scores. The manifestations associated with mortality were renal disease activity (odds ratio, OR 4.6, confidence interval, CI 95% 1.0—20.6), infections (OR 3.2 CI 95% 2.0—5.3) and thrombocytopenia (OR 4.0, CI 95% 1.0—15.9). The survival at 9.7 months was 72, 62 and 50% in patients with an SLEDAI score of 3—10, 11—20 and  21, respectively. The SLEDAI score, the presence of damage and infection were associated with death in patients with acute severe SLE. Lupus (2007) 16, 997—1000.
Key Words: acute severe SLE • damage • disease activity • survival
References
- Bernatzky S., Boivin JF, Joseph L. et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2550—2557.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Petri M., Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins lupus cohort. J Rheumatol 1992; 19: 1559—1565.[Web of Science][Medline]
[Order article via Infotrieve]
- Cervera R., Khamashta MA, Font J. et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine 2003; 82: 299—308.[Medline]
[Order article via Infotrieve]
- Petri M., Genovese M., Engle E., Hochberg M. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 1991; 34: 937—944.[Web of Science][Medline]
[Order article via Infotrieve]
- Zonana-Nacach A., Salas M., Sánchez ML, Camargo-Coronel A., Bravo-Gatica C., Mintz GJ Measurement of clinical activity of systemic lupus erythematosus and laboratory abnormalities: twelve-months prospective study. Rheumatol 1995; 22: 45—49.
- Barr SG, Zonana-Nacach A., Madger LS, Petri M. Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 2682—2688.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271—1277.[Web of Science][Medline]
[Order article via Infotrieve]
- Liang MH, Socher SA, Larson MG, Schur PH Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107—1118.[Web of Science][Medline]
[Order article via Infotrieve]
- Bombardier C., Gladman D., Urowitz M. et al. Derivation of SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 19: 53—59.
- Gladman DD, Goldsmith CH, Urowitz MB et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 2000; 27: 373—376.[Web of Science][Medline]
[Order article via Infotrieve]
- Edwards CJ, Lian TY, Badsha H., Teh CL, Arden N., Chng HH Hospitalization of individuals with systemic lupus erythematosus:characteristics and predictors of outcome. Lupus 2003; 12: 672—676.[Abstract/Free Full Text]
- Krishnan E. Hospitalization and mortality of patients with systemic lupus erythematosus. J Rheumatol 2006; 33: 1770—1774.[Abstract/Free Full Text]
- Zonana-Nacach A., Camargo-Coronel A., Yañez P. et al. Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration. Lupus 1998; 7: 119—123.[Abstract/Free Full Text]
- Zonana-Nacach A., Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 2000; 43: 1801—1808.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Cook RJ, Gladman DD, Pericak D., Urowitz MB Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol 2000; 27: 1892—1895.[Web of Science][Medline]
[Order article via Infotrieve]
- Rahman P., Gladman DD, Urowitz MB, Hallett D., Tam LS Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus 2001; 10: 93—96.[Abstract/Free Full Text]
Lupus, Vol. 16, No. 12,
997-1000 (2007)
DOI: 10.1177/0961203307083175
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
A. G. Uribe, J. Romero-Diaz, M. Apte, M. Fernandez, P. I. Burgos, J. D. Reveille, J. Sanchez-Guerrero, and G. S. Alarcon
Impact of immigration on the clinical expression of systemic lupus erythematosus: a comparative study of Hispanic patients residing in the USA and Mexico
Rheumatology,
November 1, 2009;
48(11):
1392 - 1397.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C Gomes, J. Carvalho, E. Borba, C. Borges, M. Vendramini, C Bueno, L. Costa, and E Bonfa
Digital vasculitis in systemic lupus erythematosus: a minor manifestation of disease activity?
Lupus,
October 1, 2009;
18(11):
990 - 993.
[Abstract]
[PDF]
|
|
|
|
|
